Trials / Completed
CompletedNCT00158457
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
Pilot Trial to Evaluate the Efficacy and Tolerance of a Simple Once Daily Combined Regimen Including Tenofovir (TDF), Emtricitabine (FTC) and Efavirenz (EFV) in HIV-1 Infected Patients Naive to Prior Antiretroviral Treatment in Senegal
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In the context of Sub-saharian Africa, this trial evaluate one of the most simple treatment available for HIV-1 infected patients. The combination proposed is a triple antiretroviral therapy with only one intake of 3 pills per day. This combination has already been studied in the North countries. Here in Senegal, the efficacy and the compliance to treatment will be evaluated after 24, 48 and 96 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tenofovir (TDF) | |
| DRUG | Emtricitabine (FTC) | |
| DRUG | Efavirenz (EFV) |
Timeline
- Start date
- 2004-06-01
- Completion
- 2006-12-01
- First posted
- 2005-09-12
- Last updated
- 2007-07-03
Locations
2 sites across 1 country: Senegal
Source: ClinicalTrials.gov record NCT00158457. Inclusion in this directory is not an endorsement.